Taiwan reports an 88.2% rise in COVID-19 cases as a new NB.1.8.1 variant drives a fresh wave. Authorities forecast a peak in mid-to-late June and expand rapid test supplies and antiviral stockpiles.
Taiwan's NHI will begin covering three major cancer immunotherapies from June 2025, helping over 3,000 patients save up to NT$2.47 million yearly. Discover how this policy reshapes cancer care access and equity.
